Cai Y - Search Results

1

Cai Y, Li H, Zhang Y. Cai Y, et al. Urology. 2017 Mar;101:176. doi: 10.1016/j.urology.2016.10.060. Epub 2017 Jan 5. Urology. 2017. PMID: 28065510 No abstract available.

2

iTRAQ-Based Quantitative Proteomic Analysis Identified HSC71 as a Novel Serum Biomarker for Renal Cell Carcinoma.

Zhang Y, Cai Y, Yu H, Li H. Zhang Y, et al. Among authors: cai y. Biomed Res Int. 2015;2015:802153. doi: 10.1155/2015/802153. Epub 2015 Sep 3. Biomed Res Int. 2015. PMID: 26425554 Free PMC article.

3

Successful Treatment of Coexisting Paraganglioma of the Retroperitoneum and Urinary Bladder by Intermediate-Dose 131I-MIBG Therapy: A Case Report.

Cai Y, Li HZ, Zhang YS. Cai Y, et al. Medicine (Baltimore). 2015 Oct;94(41):e1686. doi: 10.1097/MD.0000000000001686. Medicine (Baltimore). 2015. PMID: 26469903 Free PMC article.

4

Efficacy of sorafenib correlates with Memorial Sloan-Kettering Cancer Center (MSKCC) risk classification and bone metastasis in Chinese patients with metastatic renal cell carcinoma.

Zhang Y, Li Y, Cai Y, Wang K, Li H. Zhang Y, et al. Among authors: cai y. Cell Oncol (Dordr). 2016 Feb;39(1):15-21. doi: 10.1007/s13402-015-0245-5. Epub 2015 Nov 23. Cell Oncol (Dordr). 2016. PMID: 26597814

5

Downregulation of microRNA-206 suppresses clear cell renal carcinoma proliferation and invasion by targeting vascular endothelial growth factor A.

Cai Y, Li H, Zhang Y. Cai Y, et al. Oncol Rep. 2016 Mar;35(3):1778-86. doi: 10.3892/or.2015.4538. Epub 2015 Dec 30. Oncol Rep. 2016. Retraction in: Oncol Rep. 2024 Apr;51(4):58. doi: 10.3892/or.2024.8717 PMID: 26718123 Retracted.

6

IgG4-related inflammatory pseudotumor of the kidney mimicking renal cell carcinoma: A case report.

Cai YI, Li HZ, Zhang YS. Cai YI, et al. Oncol Lett. 2016 May;11(5):3438-3440. doi: 10.3892/ol.2016.4408. Epub 2016 Apr 5. Oncol Lett. 2016. PMID: 27123131 Free PMC article.

7

Re: Jaimin R. Bhatt, Patrick O. Richard, Nicole S. Kim, et al. Natural History of Renal Angiomyolipoma (AML): Most Patients with Large AMLs >4cm Can Be Offered Active Surveillance as an Initial Management Strategy. Eur Urol 2016;70:85-90.

Cai Y, Li H, Zhang Y. Cai Y, et al. Eur Urol. 2017 May;71(5):e141-e142. doi: 10.1016/j.eururo.2016.10.014. Epub 2016 Oct 18. Eur Urol. 2017. PMID: 27769715 No abstract available.

8

Re: Kapoor et al.: Evolving Strategies in the Treatment of Tuberous Sclerosis Complex-associated Angiomyolipomas (TSC-AML) (Urology 2016;89:19-26).

Cai Y, Li H, Zhang Y. Cai Y, et al. Urology. 2017 Feb;100:255. doi: 10.1016/j.urology.2016.09.049. Epub 2016 Oct 24. Urology. 2017. PMID: 27789306 No abstract available.

9

Assessment of Tuberous Sclerosis Complex Associated With Renal Lesions by Targeted Next-generation Sequencing in Mainland China.

Cai Y, Li H, Zhang Y. Cai Y, et al. Urology. 2017 Mar;101:170.e1-170.e7. doi: 10.1016/j.urology.2016.10.056. Epub 2017 Jan 5. Urology. 2017. PMID: 28065512

10

Comparison of Partial and Radical Laparascopic Nephrectomy: Long-Term Outcomes for Clinical T1b Renal Cell Carcinoma.

Cai Y, Li HZ, Zhang YS. Cai Y, et al. Urol J. 2018 Mar 18;15(2):16-20. doi: 10.22037/uj.v0i0.3913. Urol J. 2018. PMID: 29464682 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,452 results

Search Page

Filters